{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/aardvark-therapeutics-aard-faces-investor-scrutiny-amid-56-drop-on-clinical-pause-for-lead-drug-candidate-hagens-berman-302765880.html", "message": "News view counter 710510 successfully enlarged"}